Literature DB >> 11786926

Molecular cloning and characterization of human SOX17.

Masaru Katoh1.   

Abstract

SOX proteins are a family of transcription factors with high-mobility-group DNA-binding domain (HMG box) homologous to SRY, which are implicated in embryogenesis. Xenopus Sox17 alpha, Sox17 beta, and Sox3 are reported to negatively modulate the WNT - beta-catenin - TCF signaling pathway. Here, human SOX17 gene fragments were identified in human genome draft sequences by using bioinformatics, and SOX17 cDNAs were isolated by using cDNA-PCR. Human SOX17 was found to encode a 414-amino-acid protein with a HMG box, which was homologous to SOX18 and SOX7. SOX17 gene, consisting of 2 exons, was located in human chromosome 8q12-q13 region. SOX17 mRNAs of 2.5- and 2.2-kb in size were detected in adult heart, lung, spleen, testis, ovary, placenta, fetal lung, and kidney. In normal gastrointestinal tract, SOX17 mRNA was preferentially expressed in esophagus, stomach and small intestine than in colon and rectum. SOX17 mRNA was almost undetectable in human cancer cell lines HL-60, HeLa S3, K-562, MOLT-4, Raji, SW480, A549, G-361, and also in 66 cases of human primary tumors derived from various tissues, except one case of primary cervical cancer. This is the first report on molecular cloning and characterization of human SOX17.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786926

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  19 in total

Review 1.  MicroRNAs: potential regulators of renal development genes that contribute to CAKUT.

Authors:  April K Marrone; Jacqueline Ho
Journal:  Pediatr Nephrol       Date:  2013-09-03       Impact factor: 3.714

Review 2.  Development and differentiation of the intestinal epithelium.

Authors:  P de Santa Barbara; G R van den Brink; D J Roberts
Journal:  Cell Mol Life Sci       Date:  2003-07       Impact factor: 9.261

Review 3.  Sry-box (Sox) transcription factors in gastrointestinal physiology and disease.

Authors:  A D Gracz; S T Magness
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-03       Impact factor: 4.052

4.  Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.

Authors:  De-Yuan Fu; Hao-Sheng Tan; Jin-Li Wei; Chang-Ren Zhu; Ji-Xin Jiang; Yu-Xiang Zhu; Feng-Lin Cai; Mei-Hong Chong; Chuan-Li Ren
Journal:  Tumour Biol       Date:  2015-05-14

5.  SOX7 and SOX18 are essential for cardiogenesis in Xenopus.

Authors:  Chi Zhang; Tamara Basta; Michael W Klymkowsky
Journal:  Dev Dyn       Date:  2005-12       Impact factor: 3.780

6.  Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.

Authors:  Débora Sinner; Jennifer J Kordich; Jason R Spence; Robert Opoka; Scott Rankin; Suh-Chin J Lin; Diva Jonatan; Aaron M Zorn; James M Wells
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

Review 7.  The Sox transcriptional factors: Functions during intestinal development in vertebrates.

Authors:  Liezhen Fu; Yun-Bo Shi
Journal:  Semin Cell Dev Biol       Date:  2016-08-25       Impact factor: 7.727

8.  SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression.

Authors:  Yu-Mei Liao; Yang Song; Yuan-Kun Li; Jie-Hua Du; Ying Zhou
Journal:  Cancer Gene Ther       Date:  2019-09-23       Impact factor: 5.987

9.  A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.

Authors:  Wei-Lun Chang; Wu-Wei Lai; I-Ying Kuo; Chien-Yu Lin; Pei-Jung Lu; Bor-Shyang Sheu; Yi-Ching Wang
Journal:  J Gastroenterol       Date:  2016-09-26       Impact factor: 7.527

10.  Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer.

Authors:  Wei Zhang; Sabine C Glöckner; Mingzhou Guo; Emi Ota Machida; David H Wang; Hariharan Easwaran; Leander Van Neste; James G Herman; Kornel E Schuebel; D Neil Watkins; Nita Ahuja; Stephen B Baylin
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.